Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Jun;51(6):1583–1593. doi: 10.1172/JCI106956

Ouabain-specific antibodies: immunochemical properties and reversal of Na+, K+-activated adenosine triphosphatase inhibition

Thomas W Smith 1
PMCID: PMC292297  PMID: 4260123

Abstract

Antibodies with high affinity and specificity for the cardiac glycoside ouabain were raised in rabbits. The antigen used was a conjugate of ouabain linked through its rhamnose moiety to terminal α-amino groups of poly D,L alanyl-human serum albumin. Ouabain-specific antibodies were present as early as 3 wk, and rose steadily in titer over the initial 20-33 wk of immunization. Levels as high as 6.5 mg specific immunoglobulin per ml antiserum were reached in one rabbit at the end of 45 wk. The average intrinsic association constants for ouabain were 1.3 × 109 M-1 and 1.6 × 109 M-1 in antisera studied in detail, and there was evidence of restricted heterogeneity of binding site affinities. A high degree of specificity was demonstrated. Significant cross-reactivity occurred only with other cardioactive steroid compounds such as acetyl strophanthidin, digoxin, and digitoxin, while endogenous steroids did not cross-react even when present in 1000-fold excess. A rapid and convenient radioimmunoassay procedure for plasma or urine ouabain concentrations was developed using these antibodies. Competition between ouabain-3H tracer and unlabeled ouabain for specific antibody binding sites allowed the measurement of ouabain concentrations as low as 0.1 ng/ml or less without need for extraction procedures. The high association constants observed in these studies permit antibody reversal of established myocardial effects of ouabain. Both blockade and reversal of ouabain inhibition of canine myocardial microsomal Na+, K+-activated ATPase by antibody were documented, suggesting a possible mechanism for reversal of cellular effects.

Full text

PDF
1587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANFINSEN C. B., SELA M., COOKE J. P. The reversible reduction of disulfide bonds in polyalanyl ribonuclease. J Biol Chem. 1962 Jun;237:1825–1831. [PubMed] [Google Scholar]
  2. Abraham G. E., Swerdloff R., Tulchinsky D., Odell W. D. Radioimmunoassay of plasma progesterone. J Clin Endocrinol Metab. 1971 May;32(5):619–624. doi: 10.1210/jcem-32-5-619. [DOI] [PubMed] [Google Scholar]
  3. Akera T., Brody T. M. Membrane adenosine triphosphatase. The effect of potassium on the formation and dissociation of the ouabain-enzyme complex. J Pharmacol Exp Ther. 1971 Mar;176(3):545–557. [PubMed] [Google Scholar]
  4. Akera T., Larsen F. S., Brody T. M. Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation. J Pharmacol Exp Ther. 1970 May;173(1):145–151. [PubMed] [Google Scholar]
  5. Albers R. W., Koval G. J., Siegel Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase. Mol Pharmacol. 1968 Jul;4(4):324–336. [PubMed] [Google Scholar]
  6. Bentley J. D., Burnett G. H., Conklin R. L., Wasserburger R. H. Clinical application of serum digitoxin levels. A simplified plasma determination. Circulation. 1970 Jan;41(1):67–75. doi: 10.1161/01.cir.41.1.67. [DOI] [PubMed] [Google Scholar]
  7. Besch H. R., Jr, Allen J. C., Glick G., Schwartz A. Correlation between the inotropic action of ouabain and its effects on subcellular enzyme systems from canine myocardium. J Pharmacol Exp Ther. 1970 Jan;171(1):1–12. [PubMed] [Google Scholar]
  8. Brown D. M., Read A. P. Nucleotides. XLIX. The reduction of the adduct of periodate-oxidised adenosine-5' phosphate and methylamine. J Chem Soc Perkin 1. 1965 Sep;:5072–5074. doi: 10.1039/jr9650005072. [DOI] [PubMed] [Google Scholar]
  9. Butler V. P., Jr, Chen J. P. Digoxin-specific antibodies. Proc Natl Acad Sci U S A. 1967 Jan;57(1):71–78. doi: 10.1073/pnas.57.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ciofalo F., Ashe H. Ouabain-induced ventricular arrhythmia in rabbit: influence of antibodies. Life Sci I. 1971 Mar 15;10(6):341–345. doi: 10.1016/0024-3205(71)90133-0. [DOI] [PubMed] [Google Scholar]
  11. Curd J., Smith T. W., Jaton J. C., Haber E. The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2401–2406. doi: 10.1073/pnas.68.10.2401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Doherty J. E. The clinical pharmacology of digitalis glycosides: a review. Am J Med Sci. 1968 Jun;255:382–414. doi: 10.1097/00000441-196806000-00006. [DOI] [PubMed] [Google Scholar]
  13. EISEN H. N. EQUILIBRIUM DIALYSIS FOR MEASUREMENT OF ANTIBODY-HAPTEN AFFINITIES. Methods Med Res. 1964;10:106–114. [PubMed] [Google Scholar]
  14. ERLANGER B. F., BEISER S. M. ANTIBODIES SPECIFIC FOR RIBONUCLEOSIDES AND RIBONUCLEOTIDES AND THEIR REACTION WITH DNA. Proc Natl Acad Sci U S A. 1964 Jul;52:68–74. doi: 10.1073/pnas.52.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Eickenbusch W., Lahrtz H., Seppelt U., van Zwieten P. A. Serum concentration and urinary excretion of 3 H-ouabain and 3 H-digitoxin in patients suffering from hyperthyroidism or hypothyroidism. Klin Wochenschr. 1970 Mar 1;48(5):270–275. doi: 10.1007/BF01486435. [DOI] [PubMed] [Google Scholar]
  16. Evered D. C., Chapman C., Hayter C. J. Measurement of plasma digoxin concentration by radioimmunoassay. Br Med J. 1970 Aug 22;3(5720):427–428. doi: 10.1136/bmj.3.5720.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Grahame-Smith D. G. Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication. Br Med J. 1969 Feb 1;1(5639):286–289. doi: 10.1136/bmj.1.5639.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  19. KHYM J. X. The reaction of methylamine with periodate-oxidized adenosine 5'-phosphate. Biochemistry. 1963 Mar-Apr;2:344–350. doi: 10.1021/bi00902a029. [DOI] [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Langer G. A., Serena S. D. Effects of strophanthidin upon contraction and ionic exchange in rabbit ventricular myocardium: relation to control of active state. J Mol Cell Cardiol. 1970 Mar;1(1):65–90. doi: 10.1016/0022-2828(70)90029-5. [DOI] [PubMed] [Google Scholar]
  22. Langer G. A. The intrinsic control of myocardial contraction--ionic factors. N Engl J Med. 1971 Nov 4;285(19):1065–1071. doi: 10.1056/NEJM197111042851910. [DOI] [PubMed] [Google Scholar]
  23. Lee K. S., Klaus W. The subcellular basis for the mechanism of inotropic action of cardiac glycosides. Pharmacol Rev. 1971 Sep;23(3):193–261. [PubMed] [Google Scholar]
  24. Lowenstein J. M., Corrill E. M. An improved method for measuring plasma and tissue concentrations of digitalis glycosides. J Lab Clin Med. 1966 Jun;67(6):1048–1052. [PubMed] [Google Scholar]
  25. Lukas D. A., Peterson R. E. Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug. J Clin Invest. 1966 May;45(5):782–795. doi: 10.1172/JCI105393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lüllmann H., van Zwieten P. A. The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques. J Pharm Pharmacol. 1969 Jan;21(1):1–8. doi: 10.1111/j.2042-7158.1969.tb08121.x. [DOI] [PubMed] [Google Scholar]
  27. MARKS B. H., DUTTA S., GAUTHIER J., ELLIOTT D. DISTRIBUTION IN PLASMA, UPTAKE BY THE HEART AND EXCRETION OF OUABAIN-H3 IN HUMAN SUBJECTS. J Pharmacol Exp Ther. 1964 Sep;145:351–356. [PubMed] [Google Scholar]
  28. NISONOFF A., PRESSMAN D. Heterogeneity and average combining constants of antibodies from individual rabbits. J Immunol. 1958 Jun;80(6):417–428. [PubMed] [Google Scholar]
  29. Oliver G. C., Jr, Parker B. M., Brasfield D. L., Parker C. W. The measurement of digitoxin in human serum by radioimmunoassay. J Clin Invest. 1968 May;47(5):1035–1042. doi: 10.1172/JCI105793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Oliver G. C., Parker B. M., Parker C. W. Radioimmunoassay for digoxin. Technic and clinical application. Am J Med. 1971 Aug;51(2):186–192. doi: 10.1016/0002-9343(71)90237-3. [DOI] [PubMed] [Google Scholar]
  31. SCHECHTER I., BAUMINGER S., SELA M., NACHTIGAL D., FELDMAN M. IMMUNE RESPONSE TO POLYPEPTIDYL PROTEINS IN RABBITS TOLERANT TO THE PROTEIN CARRIERS. Immunochemistry. 1964 Dec;1:249–265. doi: 10.1016/0019-2791(64)90026-6. [DOI] [PubMed] [Google Scholar]
  32. Schmidt D. H., Butler V. P., Jr Immunological protecion against dixin toxicity. J Clin Invest. 1971 Apr;50(4):866–871. doi: 10.1172/JCI106558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schmidt D. H., Butler V. P., Jr Reversal of digoxin toxicity with specific antibodies. J Clin Invest. 1971 Aug;50(8):1738–1744. doi: 10.1172/JCI106663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Smith T. W., Butler V. P., Jr, Haber E. Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin. Biochemistry. 1970 Jan 20;9(2):331–337. doi: 10.1021/bi00804a020. [DOI] [PubMed] [Google Scholar]
  35. Smith T. W., Butler V. P., Jr, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med. 1969 Nov 27;281(22):1212–1216. doi: 10.1056/NEJM196911272812203. [DOI] [PubMed] [Google Scholar]
  36. Smith T. W. Radioimmunoassay for serum digitoxin concentration: methodology and clinical experience. J Pharmacol Exp Ther. 1970 Nov;175(2):352–360. [PubMed] [Google Scholar]
  37. Tobin T., Sen A. K. Stability and ligand sensitivity of (3H)ouabain binding to (Na+ + K+)ATPase. Biochim Biophys Acta. 1970 Jan 14;198(1):120–131. doi: 10.1016/0005-2744(70)90040-9. [DOI] [PubMed] [Google Scholar]
  38. Zimmering P. E., Lieberman S., Erlanger B. F. Binding of steroids to steroid-specific antibodies. Biochemistry. 1967 Jan;6(1):154–164. doi: 10.1021/bi00853a026. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES